Scientific poster title: "Evaluation of iLite® ADCC Effector cells using different CD20 target cells"
In this scientific poster, we present a comparative case study using a novel ADCC effector cell line expressing the firefly luciferase reporter gene under control of the V-variant of the FcγIIIa receptor, to compare a novel target cell line overexpressing a constant high level of a specific antigen and a homologous wild type target cell line.
The iLite technology can be adapted for many applications throughout the drug development phases including drug manufacturing processes such as the quantification of vector potency and functionality or the detection of neutralizing anti-drug antibodies (NAb).